CpG-containing oligodeoxynucleotides augment and switch the immune responses of cattle to bovine herpesvirus-1 glycoprotein D

Vaccine

Volumn 20, Issue 23-24, 2002, Pages 3014-3022

  Rankin, R ^a   Pontarollo, R ^a   Gomis, S ^a   Karvonen, B ^a   Willson, P ^a   Loehr, B I ^a   Godson, D L ^a   Babiuk, L A ^a   Hecker, R ^b   Van Drunen Littel Van Den Hurk, S ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b QIAGEN GMBH   (Germany)

Author keywords

Adjuvant; Cattle; CpG oligodeoxynucleotides

Indexed keywords

ALUMINUM POTASSIUM SULFATE; GLYCOPROTEIN D; HERPES VACCINE; IMMUNOLOGICAL ADJUVANT; OLIGODEOXYNUCLEOTIDE DERIVATIVE; VIRUS GLYCOPROTEIN; ALUMINUM SULFATE; BOVINE HERPESVIRUS TYPE 1 GLYCOPROTEINS; BOVINE HERPESVIRUS TYPE-1 GLYCOPROTEINS; CPG OLIGONUCLEOTIDE; CPG-OLIGONUCLEOTIDE; OLIGODEOXYRIBONUCLEOTIDE; VIRUS ANTIBODY; VIRUS ANTIGEN; VIRUS PROTEIN; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; EXPERIMENTAL INFECTION; HERPES VIRUS INFECTION; IMMUNE RESPONSE; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; TISSUE REACTION; WEIGHT REDUCTION; ANIMAL; ANIMAL DISEASE; BLOOD; CATTLE; CATTLE DISEASE; CELLULAR IMMUNITY; GENETICS; IMMUNOLOGY; INFECTIOUS BOVINE RHINOTRACHEITIS VIRUS; NUCLEOTIDE SEQUENCE; PATHOLOGY; SKIN;

ADJUVANTS, IMMUNOLOGIC; ALUM COMPOUNDS; ANIMAL; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; BASE SEQUENCE; CATTLE; CATTLE DISEASES; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 1, BOVINE; IMMUNITY, CELLULAR; OLIGODEOXYRIBONUCLEOTIDES; SKIN; SUPPORT, NON-U.S. GOV'T; VIRAL PROTEINS; VIRAL VACCINES; ANIMALS;

EID: 0037178315     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(02)00216-5     Document Type: Article

References (28)

1. A review of infectious bovine rhinotracheitis, shipping fever pneumonia and viral-bacterial synergism in respiratory disease of cattle
2. Epitope specificity of the protective immune response induced by individual bovine herpesvirus-1 glycoproteins
3. A comparison of biodegradable microparticles and MF59 as systemic adjuvants for recombinant gD from HSV-2
4. Systemic cytokine profiles in BALB/c mice immunized with trivalent influenza vaccine containing MF59 oil emulsion and other adjuvants
5. A severe outbreak of respiratory tract disease associated with bovine respiratory syncytial virus probably enhanced by vaccination with modified live virus
6. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine
7. CpG DNA overcomes hyporesponsiveness to hepatitis B vaccine in orangutans
8. CpG DNA induces stronger immune responses with less toxicity than other adjuvants
9. Pervasive CpG suppression in animal mitochondrial genomes
10. The role of CpG dinucleotides in DNA vaccines
11. Bacterial DNA-induced NK cell IFN-gamma production is dependent on macrophage secretion of IL-12
12. Type I interferon-mediated stimulation of T cells by CpG DNA
13. CpG motifs in bacterial DNA trigger direct B cell activation
14. Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells
15. Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA
16. Bacterial DNA induces NK cells to produce IFN-gamma in vivo and increases the toxicity of lipopolysaccharides
17. CpG DNA, a novel immune enhancer for systemic and mucosal immunization with influenza virus
18. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen
19. CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity
20. CpG-containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: A new class of vaccine adjuvants
21. Therapeutic applications of CpG-containing oligodeoxynucleotides
22. Synthetic oligodeoxynucleotides containing CpG motifs enhance immunogenicity of a peptide malaria vaccine in Aotus monkeys
23. Monocytes are required for optimum in vitro stimulation of bovine peripheral blood mononuclear cells by non-methylated CpG motifs
24. Heat-shock promoter-driven synthesis of secreted bovine herpesvirus glycoproteins in transfected cells
25. Intradermal immunization with a bovine herpesvirus-1 DNA vaccine induces protective immunity in cattle
26. Protection of cattle from BHV-1 infection by immunization with recombinant glycoprotein gIV
27. The in vivo effects of recombinant bovine herpesvirus-1 expressing bovine interferon-gamma
28. Priming by DNA immunization augments T cell responses induced by modified live bovine herpesvirus vaccine